cydy could have SEVEN human trials active or done, 5 for free by end of the year. ok so that is impressive and extremely unusual.
5 indications, 3 of which look especially promising (tnbc due to existing retrospective data, stem cell due to data for ccr5-deficient cures, mss-crc due to good start to new data)
mss RR SOC combo trial
mss livr mets combo pilot
tnbc ici combo trial
tnbc EAP trial
gbm pilot
alz pilot
LATCH pilot
5 indications, 3 of which look especially promising (tnbc due to existing retrospective data, stem cell due to data for ccr5-deficient cures, mss-crc due to good start to new data)
mss RR SOC combo trial
mss livr mets combo pilot
tnbc ici combo trial
tnbc EAP trial
gbm pilot
alz pilot
LATCH pilot
9